------------
FORM 4
------------
[ ] Check this box if no longer subject
to Section 16. Form 4 or Form 5
obligations may continue. See
Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
________________________________________________________________________________
1. Name and Address of Reporting Person*
Sherman Bernard C.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
c/o Apotex Holdings Inc.
150 Signet Drive
--------------------------------------------------------------------------------
(Street)
Weston Ontario Canada M9L 1T9
--------------------------------------------------------------------------------
(City) (State) (Zip)
________________________________________________________________________________
2. Issuer Name and Ticker or Trading Symbol
Barr Laboratories, Inc. (BRL)
________________________________________________________________________________
3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)
________________________________________________________________________________
4. Statement for Month/Day/Year
February 21, 2003
________________________________________________________________________________
5. If Amendment, Date of Original (Month/Day/Year)
________________________________________________________________________________
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|_| Director |X| 10% Owner
|_| Officer (give title below) |_| Other (specify below)
____________________________________________________________________
________________________________________________________________________________
7. Individual or Joint/Group Filing (Check Applicable Law)
|_| Form Filed by One Reporting Person
|X| Form Filed by More than One Reporting Person
________________________________________________________________________________
================================================================================
TABLE I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF,
OR BENEFICIALLY OWNED
================================================================================
5.
Amount of
2A. Securities 6.
2. Deemed Beneficially Owner-
Trans- Execution 3. 4. Owned ship 7.
action Date, if Transaction Securities Acquired (A) or Following Form: Nature of
Date any Code Disposed of (D) Reported (D) Direct Indirect
1. --------- --------- (Instr. 8) (Instr. 3 and 4) Transactions or (I) Beneficial
Title of Security (Month/ (Month/ ------------ -------------------------- (Instr. 3 Indirect Ownership
(Instr. 3) Day/Year) Day/Year) Code V Amount (A) or (D) Price and 4) (Instr.4) (Instr.4)
-----------------------------------------------------------------------------------------------------------------------------------
Common Stock 9,225,143 I By Sherman
Delaware,
Inc.
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
===================================================================================================================================
FORM 4 (CONTINUED)
TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
(E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
================================================================================
9.
Number 10.
of Owner-
Deriv- ship
ative Form
2. Secur- of
Conver- 5. 7. ities Deriv- 11.
sion Number of Title and Amount Bene- ative Nature
or Derivative 6. of Underlying 8. ficially Secur- of
Exer- 3A. 4. Securities Date Securities Price Owned ity: In-
cise Deemed Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of Follow- Direct direct
Price 3. Execut- action or Disposed Expiration Date ---------------- Deriv- ing (D) or Bene-
1. of Trans- ion Code of(D) (Month/Day/Year) Amount ative Reported In- ficial
Title of Deriv- action Date if (Instr. (Instr. 3, ---------------- or Secur- Trans- direct Owner-
Derivative ative Date Any, 8) 4 and 5) Date Expira- Number ity actions (I) ship
Security Secur- (Month/ (Month/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr.
(Instr. 3) ity Day/Year)Day/Year)Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4)
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
*If the Form is filed by more than one reporting person, See Instruction
4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
/s/ Bernard C. Sherman February 25, 2003
--------------------------------------- ------------------
**Signature of the Reporting Person Date
JOINT FILER INFORMATION
This Form 4 is being filed jointly by the following parties: (i)
Bernard C. Sherman ("Dr. Sherman"), who has sole voting and dispositive control,
as the sole trustee, of the Bernard and Honey Sherman Trust ("Sherman Trust"),
and who owns 99% of the outstanding capital stock of Sherman Holdings Inc.
("Sherman Holdings"); (ii) Sherman Trust which owns 99% of the common stock of
Shermco, Inc. ("Shermco"); (iii) Sherman Holdings which owns 99% of the
preferred stock of Shermco; (iv) Shermco which owns all of the outstanding
capital stock of Sherfam Inc. ("Sherfam"); (v) Sherfam which owns all the
outstanding capital stock of Apotex Holdings Inc. ("Apotex"); (vi) Apotex which
owns all of the outstanding capital stock of SHERMFIN, INC. ("Shermfin"); (vii)
Shermfin which owns all of the outstanding capital stock of Sherman Delaware,
Inc ("SDI"); (viii) SDI which directly owns, as of the date of this filing,
11,382,038 shares of common stock of Barr Laboratories, Inc. Pursuant to Rule
16a-1(a)(4), the filing of this Form 4 shall not be deemed to be an admission by
Dr. Sherman, Sherman Trust, Sherman Holdings, Shermco, Sherfam, Apotex and
Shermfin that any of Dr. Sherman, Sherman Trust, Sherman Holdings, Shermco,
Sherfam, Apotex and Shermfin is, for the purposes of Section 16 of the
Securities Exchange Act of 1934, the beneficial owner of any securities covered
by this Form 4.
Name: Dr. Bernard C. Sherman
Address: 150 Signet Drive, Weston,
Ontario, Canada M9L 1T9
Designated Filer: Sherman Delaware, Inc.
Issuer and Ticker Symbol: Barr Laboratories, Inc. (BRL)
Date of Event Requiring Statement: February 21, 2003
/s/ Bernard C. Sherman
Bernard C. Sherman
Name: Bernard and Honey Sherman Trust Name: Apotex Holdings Inc.
Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston,
Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9
Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc.
Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr
Laboratories, Inc. (BRL) Laboratories, Inc. (BRL)
Date of Event Date of Event
Requiring Statement: February 21, 2003 Requiring Statement: February 21, 2003
By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman
------------------ ------------------
Bernard C. Sherman Bernard C. Sherman
Sole Trustee President
Page 3 of 4
Name: Sherman Holdings Inc. Name: SHERMFIN, INC.
Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston,
Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9
Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc.
Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr
Laboratories, Inc. (BRL) Laboratories, Inc. (BRL)
Date of Event Date of Event
Requiring Statement: February 21, 2003 Requiring Statement: February 21, 2003
By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman
------------------ ------------------
Bernard C. Sherman Bernard C. Sherman
President President
Name: Shermco Inc. Name: Sherfam Inc.
Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston,
Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9
Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc.
Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr
Laboratories, Inc. (BRL) Laboratories, Inc. (BRL)
Date of Event Date of Event
Requiring Statement: February 21, 2003 Requiring Statement: February 21, 2003
By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman
------------------- ------------------
Bernard C. Sherman Bernard C. Sherman
Chairman Chairman
Page 4 of 4